面对高发生率、低感知度的HPV风险，大众该如何科学防护？结合临床经验与公共卫生实践，李侗曾总 结了四个要点。 中国青年报客户端讯（中青报·中青网记者 余冰玥）在高速滑行的雪道上，"暗冰"被视为最危险的隐患 之一——它隐藏在雪道表面之下，却可能瞬间改变运动轨迹，带来不可预期的后果。近日，单板滑雪运 动员苏翊鸣在健康科普中，将HPV（人乳头瘤病毒）感染比作"赛场上看不见的暗冰"，引起年轻群体关 注与讨论。首都医科大学附属北京佑安医院呼吸与感染性疾病科主任医师李侗曾在接受采访时表示， HPV感染的核心特征正是普遍性与隐匿性，树立"男女共防"意识很关键。 李侗曾指出，多数HPV感染者在早期并无明显症状，难以通过自身感受察觉，需要借助专业筛查。若高 危型HPV持续感染且未得到及时处理，相关风险会随着时间累积，可能发展为多种癌前病变甚至癌症。 女性持续感染高危型HPV，可能与宫颈癌及外阴癌、阴道癌等相关；男性持续感染，同样可能增加阴茎 癌、肛门癌、口咽癌等疾病风险。低危型HPV如6型、11型虽不致癌，但可导致生殖器疣，且易复发， 影响生活质量。 在临床实践中，李侗曾注意到一个长期存在的认知盲区：男性HPV感染在疾病认知、 ...

Group 1: HPV Infection and Public Awareness - HPV infection is a significant public health issue affecting both men and women, with a notable lack of awareness regarding male HPV infection risks [2][4] - In China, cervical cancer cases reached approximately 110,000 in 2020, with around 59,000 deaths, making it the second highest burden of cervical cancer globally [2] - Misconceptions persist about male HPV infection, leading to underestimation of risks and a lack of urgency in vaccination [4][5] Group 2: HPV Vaccination Developments - The nine-valent HPV vaccine has received approval for use in males aged 16-26 in China, marking a significant step towards gender-inclusive HPV prevention [3] - Currently, there are two HPV vaccines available for males: a four-valent vaccine for ages 9-26 and a nine-valent vaccine for ages 16-26, with the latter providing broader protection [6] Group 3: Market Demand and Future Projections - The HPV vaccine market in China is projected to grow from 13.5 billion yuan in 2020 to 69 billion yuan by 2030, with the nine-valent vaccine expected to capture the largest market share [8] - Despite the potential for growth, the current vaccination rate remains low, with only about 21% of women vaccinated since the introduction of the HPV vaccine in China [9][10] - There is a significant unmet demand for HPV prevention among men, which presents a substantial market opportunity as health awareness increases [10]